Parallax Volatility Advisers, L.P. Genprex, Inc. Call Options Transaction History

Parallax Volatility Advisers, L.P.

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q3 2021 Nov 15, 2021	BUY	$2.59 - $3.36 $19,425 - $25,200	7,500 Added 62.5%	19,500 $52,000
Q2 2021 Aug 16, 2021	BUY	$3.11 - $4.87 $37,320 - $58,440	12,000 New	12,000 $41,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $76.8M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.